Blog
EQS-News: JOST Werke AG: JOST increases sales and earnings in the third quarter of 2022
EQS-News: JOST Werke AG: JOST increases sales and earnings in the third quarter of 2022
EQS-News: FORTEC Elektronik AG starts the 2022/2023 financial year successfully
EQS-News: FORTEC Elektronik AG starts the 2022/2023 financial year successfully
Lenta IPJSC: Lenta Expands its Own Fleet to Include KAMAZ Compass Trucks
Lenta IPJSC: Lenta Expands its Own Fleet to Include KAMAZ Compass Trucks
![EQS-News: adesso SE on track for 2022 after record quarter: sales up 32 % to EUR 653.6 million after nine months / EBITDA increases by 13 % year on year to EUR 71.4 million before previous year’s [...]: https://upload.wikimedia.org/wikipedia/commons/thumb/f/f7/Adesso_AG_logo.svg/1024px-Adesso_AG_logo.svg.png](https://www.sharewise.com/rails/active_storage/blobs/proxy/eyJfcmFpbHMiOnsiZGF0YSI6NTc4NTE4NSwicHVyIjoiYmxvYl9pZCJ9fQ==--2588855a81f72bd61c1b9d997ba920e155efe140/1024px-Adesso_AG_logo.svg?locale=de){kind=logo}
EQS-News: adesso SE on track for 2022 after record quarter: sales up 32 % to EUR 653.6 million after nine months / EBITDA increases by 13 % year on year to EUR 71.4 million before previous year’s [...]
EQS-News: adesso SE on track for 2022 after record quarter: sales up 32 % to EUR 653.6 million after nine months / EBITDA increases by 13 % year on year to EUR 71.4 million before previous year’s [...]
EQS-News: SMT Scharf AG reports significant revenue and earnings growth
EQS-News: SMT Scharf AG reports significant revenue and earnings growth
EQS-News: Hamburger Hafen und Logistik AG: HHLA achieves good result in a challenging environment
EQS-News: Hamburger Hafen und Logistik AG: HHLA achieves good result in a challenging environment
EQS-News: Gesco AG: Group earnings for the first nine months already at the level of the full year 2021
EQS-News: Gesco AG: Group earnings for the first nine months already at the level of the full year 2021
EQS-News: MorphoSys’ Licensing Partner Roche Provides Update on Phase 3 GRADUATE Program for Gantenerumab in Early Alzheimer’s Disease
EQS-News: MorphoSys’ Licensing Partner Roche Provides Update on Phase 3 GRADUATE Program for Gantenerumab in Early Alzheimer’s Disease
EQS-Adhoc: Ad hoc: MorphoSys’ Licensing Partner Roche Provides Update on Phase 3 GRADUATE Program for Gantenerumab in Early Alzheimer’s Disease
EQS-Adhoc: Ad hoc: MorphoSys’ Licensing Partner Roche Provides Update on Phase 3 GRADUATE Program for Gantenerumab in Early Alzheimer’s Disease
EQS-News: Hypoport SE: exceptionally strong first half of 2022 followed by a weak third quarter in difficult market conditions
EQS-News: Hypoport SE: exceptionally strong first half of 2022 followed by a weak third quarter in difficult market conditions
EQS-News: Brockhaus Technologies AG: Brockhaus Technologies remains on record course after nine months – fully year forecast raised
EQS-News: Brockhaus Technologies AG: Brockhaus Technologies remains on record course after nine months – fully year forecast raised
First half results 2022/23: Growth in all regions and further progress on strategic initiatives
First half results 2022/23:
Growth in all regions and further progress on strategic initiatives
EQS-News: Vitesco Technologies Group AG: Q3 2022: Sales expectations rise for full year 2022 after solid third quarter
EQS-News: Vitesco Technologies Group AG: Q3 2022: Sales expectations rise for full year 2022 after solid third quarter
Orascom Development Holding AG: announces its Egyptian Subsidiary (ODE) 9M 2022 Financial Results
Orascom Development Holding AG: announces its Egyptian Subsidiary (ODE) 9M 2022 Financial Results
EQS-News: KWS SAAT SE & Co. KGaA: KWS posts significant growth in the first quarter - outlook raised
EQS-News: KWS SAAT SE & Co. KGaA: KWS posts significant growth in the first quarter - outlook raised
EQS-News: Vantage Towers AG: Delivering robust 6% Group revenue growth in H1 and further progressing macro site new build in Q2
EQS-News: Vantage Towers AG: Delivering robust 6% Group revenue growth in H1 and further progressing macro site new build in Q2
Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Execution of Definitive Settlement Agreements
Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Execution of Definitive Settlement Agreements
EQS-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. to Report Q3 2022 Financial Results and Operational Progress on November 22, 2022
EQS-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. to Report Q3 2022 Financial Results and Operational Progress on November 22, 2022
EQS-News: JDC Group AG: JDC grows 12 percent in first nine months of 2022 despite inflation-driven spending restraint
EQS-News: JDC Group AG: JDC grows 12 percent in first nine months of 2022 despite inflation-driven spending restraint
Achiko AG Commences Commercial Deliveries in Indonesia
Achiko AG Commences Commercial Deliveries in Indonesia
EQS-Adhoc: Vulcan Energy Resources Limited: Vulcan Energie Ressourcen GmbH has successfully developed and tested a proprietary lithium extraction sorbent for sustainable lithium extraction from the Upper Rhine G
EQS-Adhoc: Vulcan Energy Resources Limited: Vulcan Energie Ressourcen GmbH has successfully developed and tested a proprietary lithium extraction sorbent for sustainable lithium extraction from the Upper Rhine G
EQS-Adhoc: Rheinmetall AG: Rheinmetall takes over Spain’s Expal Systems S.A. / Move brings the Group new ammunition production capacity
EQS-Adhoc: Rheinmetall AG: Rheinmetall takes over Spain’s Expal Systems S.A. / Move brings the Group new ammunition production capacity
TaTaTu S.p.A.: PROPOSED CAPITAL INCREASE WITH EXCLUSION OF THE PRE-EMPTION RIGHT TO BE OFFERED TO ANIVAD CONSULTING LTD FOR AN AMOUNT EQUAL TO EURO 2,650,000
TaTaTu S.p.A.: PROPOSED CAPITAL INCREASE WITH EXCLUSION OF THE PRE-EMPTION RIGHT TO BE OFFERED TO ANIVAD CONSULTING LTD FOR AN AMOUNT EQUAL TO EURO 2,650,000
EQS-Adhoc: JDC Group AG: Adjustment of the forecast for the fiscal year 2022
EQS-Adhoc: JDC Group AG: Adjustment of the forecast for the fiscal year 2022